News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Vexim Announces the Appointment of Yves-Alain Ratron as Chief Technical Officer

9/6/2012 11:41:43 AM

September 06, 2012 -- Vexim (FR0011072602 - ALVXM)(Paris:ALVXM), a medical device company specializing in minimally invasive treatment of vertebral fractures, today announces the appointment of Yves-Alain Ratron as Chief Technical Officer. Yves-Alain Ratron, who has taken up his new position in the Management committee in September, will lead Vexim's R&D, Innovation, Manufacturing and Supply Chain departments.

Over the last 30 years, Yves-Alain has built an impressive experience in the global orthopedic industry building and leading the Global R&D Department for the Tornier S.A Group that he joined in 1982. During his tenure he had several positions in Ireland, Grenoble, Canada in both R&D and Production functions. His last assignment from 2007 was Director of Global Research. Yves-Alain Ratron began his career at RALT Cars Ltd - Weybridge UK, a company specialized in producing Formula 2 and Formula 3 race cars for motor sport competitions.

Yves-Alain Ratron has a Bachelor's Degree in Mechanical Engineering from the National School of Engineering of Tarbes.

Vincent Gardès, CEO of Vexim comments: « We are very pleased to welcome Yves-Alain Ratron whose 30 years' experience in R&D, Innovation and Production in the orthopedic industry represents a considerable asset to achieve our ambitious strategy in developing new products that will always be at the forefront of innovation. »

Next press release: Results for the first half of 2012 on September 20th 2012, before market

About Vexim, the innovative back microsurgery specialist

Based in Balma, near Toulouse (France), Vexim is a medical device specialist created in February 2006 following its spinoff from Teknimed, a world leader in bone substitutes and surgical cements. Vexim has specialised in the creation and marketing of mini-invasive solutions for treating spinal pathologies. Benefitting from the financial support of its longstanding shareholders, Truffle Capital and Banexi Venture, and from OSEO public subsidies, Vexim has designed and developed the SpineJack®, a unique implant capable of repairing a deformed or fractured vertebra and correcting the anatomy of the spinal column. The Company currently has 35 staff. It has its own sales teams in France, Germany and Italy, as well as distributors in Spain, Portugal, Italy, Turkey, Argentina and South Africa.

For further information, please go to

SpineJack®, a revolutionary implant for treating Vertebral Compression Fractures

The revolutionary aspect of the SpineJack® lies in its ability to restore a fractured vertebra to its original shape, restore the spinal column's optimal anatomy and thus remove pain and enable the patient to recover their functional capabilities. Thanks to a specialised range of instruments, inserting the implants into the vertebra is carried out in a mini-invasive manner, guided by X-ray, in less than 30 minutes, enabling the patient to be discharged shortly after surgery. The SpineJack® range consists of 3 titanium implants with 3 different diameters, thus covering 95% of vertebral compression fractures and all patient morphologies.

SpineJack® technology benefits from the support of international scientific experts in the field of spinal columns, good medical-expense reimbursement systems in Europe and worldwide patent protection through to 2029.

Photos/Multimedia Gallery Available:


Vincent Gardès


Tel.: +33 5 61 48 48 38



Investor Relations & Financial Communications

Dusan Oresansky /

Emmanuel Huynh

Tel.: +33 1 44 71 94 92


Alize RP

Press relations

Caroline Carmagnol

Tel.: +33 6 64 18 99 59

Read at

comments powered by Disqus